Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoo Sato

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Microbiology|August 10, 2018
Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease ActivityTomoo Sato, Naoko Yagishita, Keiko Tamaki, et al.
Frontiers in Microbiology|October 2, 2019
Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic ParaparesisKeiko Tamaki, Tomoo Sato, Jun Tsugawa, et al.
Plos One|August 6, 2009
Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorderYoshihisa Yamano, Natsumi Araya, Tomoo Sato, et al.
Brain : a Journal of Neurology|April 24, 2023
Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathyTomoo Sato, Junji Yamauchi, Naoko Yagishita, et al.
Arthritis and Rheumatism|March 2, 2006
Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilageTomoo Sato, Koji Konomi, Satoshi Yamasaki, et al.
Antiviral Therapy|February 12, 2011
Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological diseaseNatsumi Araya, Katsunori Takahashi, Tomoo Sato, et al.
Neurology. Genetics|May 8, 2024
Large-Scale Whole-Genome Analysis of HTLV-1-Associated Myelopathy Identified Hereditary Spastic ParaplegiasNaoki Takao, Naoko Yagishita, Natsumi Araya, et al.
Plos Neglected Tropical Diseases|October 17, 2013
CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesisTomoo Sato, Ariella Coler-Reilly, Atae Utsunomiya, et al.
The Journal of Infectious Diseases|August 9, 2014
Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathyJunji Yamauchi, Ariella Coler-Reilly, Tomoo Sato, et al.
Brain : a Journal of Neurology|July 30, 2013
Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathyHitoshi Ando, Tomoo Sato, Utano Tomaru, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Microbiology|August 10, 2018
Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease ActivityTomoo Sato, Naoko Yagishita, Keiko Tamaki, et al.
Frontiers in Microbiology|October 2, 2019
Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic ParaparesisKeiko Tamaki, Tomoo Sato, Jun Tsugawa, et al.
Plos One|August 6, 2009
Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorderYoshihisa Yamano, Natsumi Araya, Tomoo Sato, et al.
Brain : a Journal of Neurology|April 24, 2023
Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathyTomoo Sato, Junji Yamauchi, Naoko Yagishita, et al.
Arthritis and Rheumatism|March 2, 2006
Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilageTomoo Sato, Koji Konomi, Satoshi Yamasaki, et al.
Antiviral Therapy|February 12, 2011
Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological diseaseNatsumi Araya, Katsunori Takahashi, Tomoo Sato, et al.
Neurology. Genetics|May 8, 2024
Large-Scale Whole-Genome Analysis of HTLV-1-Associated Myelopathy Identified Hereditary Spastic ParaplegiasNaoki Takao, Naoko Yagishita, Natsumi Araya, et al.
Plos Neglected Tropical Diseases|October 17, 2013
CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesisTomoo Sato, Ariella Coler-Reilly, Atae Utsunomiya, et al.
The Journal of Infectious Diseases|August 9, 2014
Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathyJunji Yamauchi, Ariella Coler-Reilly, Tomoo Sato, et al.
Brain : a Journal of Neurology|July 30, 2013
Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathyHitoshi Ando, Tomoo Sato, Utano Tomaru, et al.
Pageof 9